117 related articles for article (PubMed ID: 8342538)
1. Lymphoproliferative disease of "LAK cell" precursor large granular lymphocytes in association with celiac disease.
Lopez P; Morris DG; Galbraith PR; Lillicrap DP; Pross HF
Am J Hematol; 1993 Jun; 43(2):116-22. PubMed ID: 8342538
[TBL] [Abstract][Full Text] [Related]
2. Characteristic expansion of CD45RA CD27 CD28 CCR7 lymphocytes with stable natural killer (NK) receptor expression in NK- and T-cell type lymphoproliferative disease of granular lymphocytes.
Mitsui T; Maekawa I; Yamane A; Ishikawa T; Koiso H; Yokohama A; Handa H; Matsushima T; Tsukamoto N; Murakami H; Nojima Y; Karasawa M
Br J Haematol; 2004 Jul; 126(1):55-62. PubMed ID: 15198732
[TBL] [Abstract][Full Text] [Related]
3. Lymphocytes of a patient with lymphoproliferative disease of large granular lymphocytes express high natural killer, ADCC, and LAK activity.
Sansoni P; Girasole G; Manara GC; Snelli G; Passeri G; Allavena P; Rossi V; De Panfilis G; Passeri M
Clin Immunol Immunopathol; 1990 Jul; 56(1):9-21. PubMed ID: 2141560
[TBL] [Abstract][Full Text] [Related]
4. Clonally expanded CD3+, CD4-, CD8- cells bearing the alpha/beta or the gamma/delta T-cell receptor in patients with the lymphoproliferative disease of granular lymphocytes.
Pandolfi F; Foa R; De Rossi G; Zambello R; Chisesi T; di Celle PF; Migone N; Casorati G; Scarselli E; Ensoli F
Clin Immunol Immunopathol; 1991 Sep; 60(3):371-83. PubMed ID: 1830831
[TBL] [Abstract][Full Text] [Related]
5. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis.
Semenzato G; Zambello R; Starkebaum G; Oshimi K; Loughran TP
Blood; 1997 Jan; 89(1):256-60. PubMed ID: 8978299
[TBL] [Abstract][Full Text] [Related]
6. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
[TBL] [Abstract][Full Text] [Related]
7. Large natural killer cell lymphoma arising from an indolent natural killer cell large granular lymphocyte proliferation.
Roullet MR; Cornfield DB
Arch Pathol Lab Med; 2006 Nov; 130(11):1712-4. PubMed ID: 17076536
[TBL] [Abstract][Full Text] [Related]
8. Development of lymphoproliferative disorder of granular lymphocytes in association with hairy cell leukemia.
Xie XY; Sorbara L; Kreitman RJ; Fukushima PI; Kingma DW; Stetler-Stevenson M
Leuk Lymphoma; 2000 Mar; 37(1-2):97-104. PubMed ID: 10721773
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD55 and CD59 on peripheral blood cells in patients with lymphoproliferative disease of granular lymphocytes.
Isoda A; Tsukamoto N; Mitsui T; Yamane A; Hatsumi N; Matsushima T; Murakami H; Nojima Y; Karasawa M
Int J Lab Hematol; 2007 Feb; 29(1):52-7. PubMed ID: 17224008
[TBL] [Abstract][Full Text] [Related]
10. Long-term cultures of human peripheral blood lymphocytes with recombinant human interleukin-2 generate a population of virtually pure CD3+ CD16- CD56- large granular lymphocyte LAK cells.
Roussel E; Gerrard JM; Greenberg AH
Clin Exp Immunol; 1990 Nov; 82(2):416-21. PubMed ID: 1700746
[TBL] [Abstract][Full Text] [Related]
11. Clonal studies of CD3- lymphoproliferative disease of granular lymphocytes.
Nash R; McSweeney P; Zambello R; Semenzato G; Loughran TP
Blood; 1993 May; 81(9):2363-8. PubMed ID: 8097633
[TBL] [Abstract][Full Text] [Related]
12. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
[TBL] [Abstract][Full Text] [Related]
13. Close resemblance between chemokine receptor expression profiles of lymphoproliferative disease of granular lymphocytes and their normal counterparts in association with elevated serum concentrations of IP-10 and MIG.
Momose K; Makishima H; Ito T; Nakazawa H; Shimodaira S; Kiyosawa K; Ishida F
Int J Hematol; 2007 Aug; 86(2):174-9. PubMed ID: 17875534
[TBL] [Abstract][Full Text] [Related]
14. ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL).
Epling-Burnette PK; Bai F; Wei S; Chaurasia P; Painter JS; Olashaw N; Hamilton A; Sebti S; Djeu JY; Loughran TP
Oncogene; 2004 Dec; 23(57):9220-9. PubMed ID: 15516985
[TBL] [Abstract][Full Text] [Related]
15. Induction of cytotoxicity by interleukin-2 in T gamma-lymphoproliferative disorders.
Allavena P; Introna M; Rambaldi A; Zanaboni F; Rossini S; Villa A; Bassan R; Barbui T; Mantovani A
Int J Cancer; 1986 Jan; 37(1):27-33. PubMed ID: 3079743
[TBL] [Abstract][Full Text] [Related]
16. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
Bayle C; Vitté-Mony I; Lang P; Pico J; Hercend T; Bertoglio J
Leukemia; 1992 May; 6(5):470-6. PubMed ID: 1375700
[TBL] [Abstract][Full Text] [Related]
17. DNA microarray analysis of T cell-type lymphoproliferative disease of granular lymphocytes.
Makishima H; Ishida F; Ito T; Kitano K; Ueno S; Ohmine K; Yamashita Y; Ota J; Ota M; Yamauchi K; Mano H
Br J Haematol; 2002 Aug; 118(2):462-9. PubMed ID: 12139733
[TBL] [Abstract][Full Text] [Related]
18. Large granular lymphocyte proliferation with the natural killer-cell phenotype.
Chan WC; Gu LB; Masih A; Nicholson J; Vogler WR; Yu G; Nasr S
Am J Clin Pathol; 1992 Mar; 97(3):353-8. PubMed ID: 1543158
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.
McKenzie RS; Simms PE; Helfrich BA; Fisher RI; Ellis TM
Cancer Res; 1992 Nov; 52(22):6318-22. PubMed ID: 1384959
[TBL] [Abstract][Full Text] [Related]
20. DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3-CD56+ fractions.
Choi YL; Makishima H; Ohashi J; Yamashita Y; Ohki R; Koinuma K; Ota J; Isobe Y; Ishida F; Oshimi K; Mano H
Leukemia; 2004 Mar; 18(3):556-65. PubMed ID: 14737071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
